Excited to share our conversation with Jeremy Elser, founder and CEO of Ship of Theseus, a pioneering biotechnology company. Jeremy recently won the EWMA Innovation Competition, and in this interview, he shares insights into his journey, their groundbreaking work in wound care, and the future of Ship of Theseus.
Key takeaways from the interview:
🌍 Ship of Theseus’ mission: Leveraging cutting-edge biotechnology to improve wound healing through transcription factor-based treatments.
🏆 Impact of winning the EWMA Innovation Award: Boosting the company’s recognition and opening doors to new partnerships and collaborations.
🔬 Exciting pipeline: Their lead product, Trireme, is set to enter clinical trials by 2025.
Don’t miss this insightful conversation!